Envista Holdings Corp (NVST) Stock
NVST Key Statistics
About Envista Holdings Corp
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
CEO: Paul A. Keel. Company website
NVST — Frequently Asked Questions
What is the NVST stock price today?
Envista Holdings Corp (NVST) trades at $23.35, down 1.44% on the day, as of Sep 20, 2026 14:59 UTC.
What is Envista Holdings Corp's market cap?
Envista Holdings Corp has a market capitalisation of $3.80B, calculated from the live NVST share price and shares outstanding.
What is the P/E ratio of NVST?
NVST trades at a trailing P/E of 40.26, from earnings per share of $0.58 over the last twelve months.
How much revenue does Envista Holdings Corp make?
Envista Holdings Corp generated revenue of $2.86B over the trailing twelve months, which puts the stock at 1.33 times sales.
What is the 52-week range for NVST?
NVST has traded between $18.77 and $30.36 over the past 52 weeks, and the last price is 23.1% below that high.
Is Envista Holdings Corp profitable?
Yes. Envista Holdings Corp keeps 3.33% of revenue as net income over the trailing twelve months.
What is the analyst price target for NVST?
Wall Street analysts rate NVST Hold, with an average price target of $29.50, 26.3% above the current price.
What sector is Envista Holdings Corp in?
Envista Holdings Corp is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US.
Who is the CEO of Envista Holdings Corp?
Paul A. Keel is the chief executive of Envista Holdings Corp, which employs 12,000 people.
Where can I track NVST in real time?
QFI Terminal shows NVST with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See NVST live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open NVST in Terminal See plans